FeaturesSignalPricingFounders
Log inGet started free
SV

Sanofi Ventures

Corporate VCActive

Sanofi Ventures operates as the corporate venture capital arm of Sanofi.

Cambridge, United StatesFounded 2019sanofiventures.com/
37
Investments
4
Exits
—
AUM
10.8%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sanofi Ventures.

Get started free

Investment Thesis & Strategy

Sanofi Ventures, as a CVC, invests in various stages across biotech, fintech, and healthcare companies, seeking strategic alignment with Sanofi's core business and potential for innovation.

Investment Activity

Deals per year over the last 9 years

1
2015
1
2016
0
2017
0
2018
1
2019
0
2020
7
2021
1
2022
1
2023

Portfolio Companies

Selected investments from their portfolio of 37 companies

A
Aqemia
AI/ML · Series A, 2023
Active
X
Xilis
Biotech · Series A, 2022
Active
T
Tessera Therapeutics
Biotech · Series B, 2021
Active
A
Alentis Therapeutics
Biotech · Series A, 2021
Active
I
InveniAI
AI/ML · Series B, 2021
Active
I
InstaDeep
AI/ML · Series A, 2021
Active
K
Kyverna Therapeutics
Biotech · Series B, 2021
Active
B
BioAge Labs
Biotech · Series B, 2021
Active
I
Iktos
AI/ML · Series A, 2021
Active
O
Owkin
Biotech · Series A, 2019
Active
A
Amunix Pharmaceuticals
Biotech · Series B, 2016
Active
E
Evotec
Biotech · Growth, 2015
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Translate BioAcquisition2021$3.2B
Kiadis PharmaAcquisition2021$410M
Innate PharmaIPO2006—
Alnylam PharmaceuticalsIPO2004—

Frequently Asked Questions

Sanofi Ventures focuses on Series A, Series B stage investments.

Related Investors

SR One

Cambridge, United States · 144 deals

Johnson & Johnson Innovation – JJDC

Cambridge, United States · 34 deals

Johnson & Johnson Innovation вАУ JJDC

Cambridge, United States · 34 deals

Baxalta Ventures

Cambridge, United States · 6 deals

Partners HealthCare Innovation

Cambridge, United States · 1 deals

Brand Capital

Mumbai, India · 570 deals